VIVOLTA is a contract development and manufacturing organisation (CDMO) focused on the development, scale-up and commercial manufacture of electrospun medical devices. Rooted in a heritage as an electrospinning equipment designer, the company now integrates materials science, application development, custom engineering and large-scale manufacturing under one roof. Using its proprietary MediSpin™ platform, VIVOLTA enables clients in the medtech and pharma sectors to bring electrospun biomaterials—such as nano- and micro-fibre scaffolds for implants and drug-delivery systems—from concept through to commercial production. VIVOLTA operates from its ISO 13485-certified facility and offers both development and manufacturing services from feasibility stage to full commercial output.

Key products and services:

• Concept development and feasibility testing of electrospun biomaterials.
• Product & process development, including materials science, application engineering and regulatory readiness.
• Process scale-up, validation and commercial manufacturing of implantable electrospun medical devices.
• Contract manufacturing with clean-room ISO Class 7 production, leveraging the MediSpin™ automated electrospinning production platform.
• Integrated formatting and post-process services such as laser cutting, packaging and labelling, plus end-to-end supply-chain integration.

With its distinctive combination of electrospinning technology, development expertise and manufacturing capacity, VIVOLTA offers a unique value-proposition for clients seeking next-generation medical implants and high-volume production. By concentrating design, scale-up and manufacturing in a single integrated platform, the company is positioned to support the growing demand for regenerative medical products built on biomimetic electrospun materials.